Regola la misura dello schermo
Resize out
Resize in
Resize Resetta
Done Fatto
CureVac - Ingmar Hoerr, CEO

CureVac - Ingmar Hoerr, CEO

Visto 1,215 volte

Validazione umana

8.1
Grazie! Il tuo voto è stato registrato e verrà presto pubblicato.
No
Descrizione del video:

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

Aggiunto 29 Mar 2017
Commenti